Scott M. Coiante - 28 Feb 2026 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Chief Financial Officer
Signature
/s/ Scott M. Coiante
Issuer symbol
LXRX
Transactions as of
28 Feb 2026
Net transactions value
-$80,675
Form type
4
Filing time
03 Mar 2026, 07:16:31 UTC
Previous filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Scott M. Coiante filed Form 4 for LEXICON PHARMACEUTICALS, INC. (LXRX) on 03 Mar 2026."

Quick Takeaways

  • This page summarizes Scott M. Coiante's Form 4 filing for LEXICON PHARMACEUTICALS, INC. (LXRX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 03 Mar 2026, 07:16.

What Changed

  • Previous filing in this sequence was filed on 17 Feb 2026.
  • Current net transaction value: -$80,675.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coiante Scott M SVP, Chief Financial Officer 2445 TECHNOLOGY FOREST BLVD, 11TH FLOOR, SPRING /s/ Scott M. Coiante 03 Mar 2026 0001608536

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +160,237 160,237 28 Feb 2026 Direct F1
transaction LXRX Common Stock Tax liability $80,675 -54,881 -34% $1.47 105,356 28 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -160,237 -33% 320,473 28 Feb 2026 Common Stock 160,237 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Sponsored